Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters

Abstract

In the adenoviral system only the mlc-2v promoter may fulfil the safety requirements for a myocardial specific gene expression with a high selectivity for the ventricular myocardium, thus providing a promising tool for future gene therapy of cardiomyopathies.